| Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases (NCT01713699) | The Netherlands Cancer Institute | 2012-09-01 |
| PET Evaluation of Recurrent Differentiated Thyroid Cancer (NCT01641679) | The Netherlands Cancer Institute | 2012-08-01 |
| Prospective Pilot Study ANDPrecise (NCT02292407) | The Netherlands Cancer Institute | 2012-06-01 |
| Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC (NCT01562210) | The Netherlands Cancer Institute | 2012-04-01 |
| Study With T-cel Receptor Gene Therapy in Metastatic Melanoma (NCT02654821) | The Netherlands Cancer Institute | 2012-03-01 |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (NCT01543672) | The Netherlands Cancer Institute | 2011-11-22 |
| The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics (NCT01562431) | The Netherlands Cancer Institute | 2011-10-01 |
| Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors (NCT01286896) | The Netherlands Cancer Institute | 2011-04-11 |
| Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (NCT01359397) | The Netherlands Cancer Institute | 2011-03-01 |
| Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (NCT02106312) | The Netherlands Cancer Institute | 2010-12-15 |
| Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir (NCT01173913) | The Netherlands Cancer Institute | 2010-09-01 |
| Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer (NCT01164995) | The Netherlands Cancer Institute | 2010-07-01 |
| Combined Modality Treatment of Sarcomas of the Extremities (NCT01985295) | The Netherlands Cancer Institute | 2010-06-01 |
| Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC (NCT01024829) | The Netherlands Cancer Institute | 2010-05-01 |
| Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (NCT01057069) | The Netherlands Cancer Institute | 2010-01-01 |
| Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer (NCT01024582) | The Netherlands Cancer Institute | 2009-10-01 |
| Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma (NCT01211275) | The Netherlands Cancer Institute | 2009-05-22 |
| Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients (NCT00783822) | The Netherlands Cancer Institute | 2008-11-01 |
| Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (NCT00768859) | The Netherlands Cancer Institute | 2008-09-01 |
| Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer (NCT00738777) | The Netherlands Cancer Institute | 2008-07-01 |
| Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer (NCT00684216) | The Netherlands Cancer Institute | 2008-04-01 |
| Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial (NCT00582244) | The Netherlands Cancer Institute | 2008-01-01 |
| Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity (NCT00459771) | The Netherlands Cancer Institute | 2007-06-01 |
| Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines (NCT00838370) | The Netherlands Cancer Institute | 2007-05-01 |
| Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD (NCT00448266) | The Netherlands Cancer Institute | 2007-05-01 |
| Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer (NCT00426257) | The Netherlands Cancer Institute | 2007-02-01 |
| Radiation Dose Intensity Study in Breast Cancer in Young Women (NCT00212121) | The Netherlands Cancer Institute | 2004-07-01 |
| Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose (NCT00692107) | The Netherlands Cancer Institute | 1997-06-01 |